CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors
| Image |  |
|---|---|
| Description | scientific article published on 14 December 2015 |
| Author/s |
author: Timothy R Hercus Michael W Parker Louis Fabri Urmi Dhagat Angel F. Lopez |
| Publication date | December 14, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |